These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15518048)

  • 61. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM; Gazda A; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract]   [Full Text] [Related]  

  • 63. [Anti-phospholipid syndrome: diagnosis and management].
    Ieko M
    Rinsho Ketsueki; 2014 Aug; 55(8):917-24. PubMed ID: 25186481
    [No Abstract]   [Full Text] [Related]  

  • 64. Antiphospholipid syndrome: multiple mechanisms.
    Mackworth-Young CG
    Clin Exp Immunol; 2004 Jun; 136(3):393-401. PubMed ID: 15147339
    [No Abstract]   [Full Text] [Related]  

  • 65. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The antiphospholipid syndrome and infections in a child with trisomy 21.
    Hoxha A; Calligaro A; Bortolati M; Tonello M; Guariso G; Ruffatti A
    Autoimmun Rev; 2008 Dec; 8(2):121-3. PubMed ID: 18573354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive?
    Kovacs MR; Lazo-Langner A; Kovacs MJ
    Thromb Res; 2020 Oct; 194():119-120. PubMed ID: 32788103
    [No Abstract]   [Full Text] [Related]  

  • 68. Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodies.
    Galland J; Mohamed S; Revuz S; de Maistre E; de Laat B; Marie PY; Zuily S; Lévy B; Regnault V; Wahl D
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):580-2. PubMed ID: 27380476
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC?
    Hess EV
    J Rheumatol; 1998 Feb; 25(2):200-2. PubMed ID: 9489806
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunology of the antiphospholipid antibody syndrome.
    Roubey RA
    Arthritis Rheum; 1996 Sep; 39(9):1444-54. PubMed ID: 8814055
    [No Abstract]   [Full Text] [Related]  

  • 71. Prevention of miscarriage in antiphospholipid syndrome.
    Passaleva A; Massai G; D'Elios MM; Livi C; Abbate R
    Autoimmunity; 1992; 14(2):121-5. PubMed ID: 1303678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
    Ordi-Ros J; Pérez-Pemán P; Monasterio J
    Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome).
    Balasch J; Reverter JC; Creus M; Tàssies D; Fábregues F; Carmona F; Font J; Vanrell JA
    Hum Reprod; 1999 Aug; 14(8):1956-9. PubMed ID: 10438407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.
    Lakos G; Favaloro EJ; Harris EN; Meroni PL; Tincani A; Wong RC; Pierangeli SS
    Arthritis Rheum; 2012 Jan; 64(1):1-10. PubMed ID: 21953634
    [No Abstract]   [Full Text] [Related]  

  • 75. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
    Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
    Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Audit of laboratory investigation of antiphospholipid syndrome.
    Myers B; Dolan G; Gould J
    Br J Haematol; 2001 Oct; 115(1):229. PubMed ID: 11722438
    [No Abstract]   [Full Text] [Related]  

  • 77. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
    Silver RM; Pierangeli SS; Edwin SS; Umar F; Harris EN; Scott JR; Branch DW
    Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Laboratory tests for the antiphospholipid syndrome.
    Pericleous C; Ripoll VM; Giles I; Ioannou Y
    Methods Mol Biol; 2014; 1134():221-35. PubMed ID: 24497366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lupus anticoagulant testing.
    Moffat K; Raby A; Crowther M
    Methods Mol Biol; 2013; 992():97-108. PubMed ID: 23546707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.